Skip to content

Home and Community Use of a Suspension Walker in Pre-Walking Infants With Down Syndrome

Feasibility of a Novel Overground Stepping Intervention for Pre-Walking Infants With Down Syndrome

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07631130
Enrollment
12
Registered
2026-06-05
Start date
2026-09-01
Completion date
2028-08-01
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Keywords

Down syndrome, infant, mobility device, walker, walking, early intervention

Brief summary

The goal of this clinical trial is to learn if pre-walking infants with Down syndrome can use a suspension walker in their home and community environments. The main questions it aims to answer are: * Is suspension walker intervention feasible for pre-walking infants with Down syndrome? * What are barriers to successfully using suspension walkers in home and community environments? * What are facilitators for successfully using suspension walkers in home and community environments? Participants will: * Use a suspension walker in the home and community for a three-month period (goal 20 minutes/day, 5 days/week) * Meet with a therapist three times in their home to learn how to use the walker * Track how often they use the walker for one week each month * Complete assessments of infants' gross motor skill and ability to use the walker before and after the three-month period * Be interviewed after the three-month period about their experiences using the walker

Interventions

BEHAVIORALsuspension walker

Parents will be provided with a pediatric suspension walker and instructed to use the walker with their infant at least 20 total min/day, 5 days/week. Parents will be instructed in 3 activity types: 1) Adult-propelled stepping consists of the caregiver moving the walker along the floor to prompt the infant to step. 2) Self-propelled walking consists of encouraging the infant to step independently to propel the walker, with intermittent assistance from the caregiver as needed. 3) Play consists of a variety of mobile and stationary play activities, adapted to the child's interests, engaged in while supported in the walker. Parents will brainstorm with the therapist to select play activities and to determine where and when to perform stepping and walking activities. This may include home- and community-based locations, including larger rooms in the home, hallways, sidewalks, parks, and indoor community spaces like supermarkets or shopping malls.

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Months to 13 Months
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Down syndrome * 10-13 months of age * Able to sit independently * Unable to walk independently

Exclusion criteria

* Medical or orthopedic conditions other than Down syndrome that prevent standing or walking

Design outcomes

Primary

MeasureTime frameDescription
participation in instructed dosagefirst week of each month for three monthsDichotomous: Was the family able to use the walker for the instructed 20 minutes/day, 5 days/week?

Secondary

MeasureTime frameDescription
usage frequency and durationfirst week of each month for three monthsminutes per day, days per week
steps per minutefirst week of each month for three monthssteps per minute while using walker (measured by StepWatch step counters)
gross motor function0 and 3 monthsGross Motor Function Measure-88
stepping ability0 and 3 monthsrate of alternating steps while the walker is moved by an adult
walker propulsion0 and 3 monthsDichotomous: Was the infant able to propel the walker without assistance?

Contacts

CONTACTKari S Kretch
kretch@usc.edu323-442-3364
CONTACTLearning, Development, and Rehabilitation Lab
learninglab@usc.edu(323) 442-3119
PRINCIPAL_INVESTIGATORKari S Kretch, PT, DPT, PhD

University of Southern California

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026